Villaren, Baby Girl .

HRN: 28-84-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/18/2026
04/25/2026
IV
30mg
Q24hrs
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: